TLR9 and breast cancer: Inherent defects in specifically the breast cancer CIC population PPRs TLR2 and TLR9 are likely to contribute to dysfunction in the initiation of the type I IFN response leading to a failure of feed-forward signal amplification via IRFs and STAT signaling.